This post was written by Glenn Sabin at FON Therapeutics
I am often asked what’s the best clinic or business model to deliver integrative medicine. Frankly, when deciding the most appropriate, sustainable model for your specific organization, there are many important considerations.
Recently, I led a workshop at the Society for Integrative Oncology (SIO) titled A Practical Look at Current Clinic and Business Models for Academic and Private Integrative Oncology Centers, and What the Future Portends. Panelists included representatives from an Ottawa based non-profit clinic, a major U.S. academic cancer center, and two private community centers: a direct pay (insurance read more…
Nigel Plummer PhD and Sue Plummer PhD
What is a probiotic?
For centuries living microorganisms, particularly lactic acid bacteria (producers of lactic acid from sugar) have been used in food preservation so there has been a long term awareness of the beneficial effects of microorganisms. However, the first reports of beneficial effects on human health linked to lactobacilli and bifidobacteria appeared in the late 19th/early 20th century (Tannock, 2003). read more…
Chenggang Jin, PhD, MDa,b, Deanna J. Fall, BAc, Diana Roen BS,a and Gottfried Kellermann, PhDc
Lyme disease is the most reported vectorborne illness in the United States. The incidence may be vastly under-reported due to limitations of current testing methodologies; the need for more sensitive and specific tests is apparent. The iSpot LymeTM assay is a new generation of in vitro diagnostic test for the detection of antigen-specific effector/memory T cells that respond to stimulation by Borrelia burgdorferi antigens. The highly sensitive T cell-based enzyme-linked immunospot (ELISPOT) methodology enumerates the Borrelia burgdorferi activated effector/memory T cells. This assay is read more…
Shawn A. Tassone, MD
With the increasing numbers of women entering the baby boomer generation, and the
average age of menopause in the United States hovering around 51, now more than ever is an opportunity for health care providers to instruct female patients how to eat through menopause. The National Institutes of Health recognize women entering menopause are at an increased risk for chronic disease, and an increased reliance on medicines and the medical field (Bleil, 2011). The purpose of this paper is to examine some of the more common symptoms of menopause for which women turn to medication read more…
Michael Friedman, N.D.
Ocular melanoma is characterized by a high rate of liver metastases. The median survival time is less than five months. There is no standard allopathic therapy for this condition.1
Although therapies based on the treat- ments of metastatic cutaneous melanoma have been tried, the conventional treatment of intravenous and intra-arterial hepatic infusions are usually futile. Systemic chemotherapies may cause temporary shrinkage of a tumor but will not cure the disease. Although the less toxic hepatic arterial infusion increases tumor shrinkage, there is no clear difference in survival rates between the two methods.2 read more…